Dayou Ma

Changsha, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Silybin Derivative B1 Inhibits Myofibroblast Activation via Wnt/DAAM2 and Ameliorates Oral Submucous Fibrosis in Mice.

Silybin Derivative B1 Inhibits Myofibroblast Activation via Wnt/DAAM2 and Ameliorates Oral Submucous Fibrosis in Mice.

Journal: International dental journal

Published: March 25, 2026

Spinosyn A derivatives as ASS1 activators and tumor inhibitors.

Spinosyn A derivatives as ASS1 activators and tumor inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: October 30, 2025

Discovery of a novel napabucasin derivative B16 as a potent STAT3 inhibitor for the treatment of triple-negative breast cancer.

Discovery of a novel napabucasin derivative B16 as a potent STAT3 inhibitor for the treatment of triple-negative breast cancer.

Journal: European journal of medicinal chemistry

Published: August 02, 2025

Discovery of a Novel Silybin Derivative for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis.

Discovery of a Novel Silybin Derivative for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis.

Journal: Journal of medicinal chemistry

Published: June 10, 2025

LM2I leads to CAD ubiquitination and liver cancer suppression through activation of ASS1.

LM2I leads to CAD ubiquitination and liver cancer suppression through activation of ASS1.

Journal: Acta biochimica et biophysica Sinica

Published: May 31, 2025

ASS1 inhibits liver cancer by promoting CAD ubiquitination and reversing the urea cycle and pyrimidine synthesis imbalance.

ASS1 inhibits liver cancer by promoting CAD ubiquitination and reversing the urea cycle and pyrimidine synthesis imbalance.

Journal: Hepatology communications

Published: February 07, 2025

Design, Synthesis, and Biological Activity of Novel Quinone Derivatives as Potent STAT3 Inhibitors for Psoriasis Treatment.

Design, Synthesis, and Biological Activity of Novel Quinone Derivatives as Potent STAT3 Inhibitors for Psoriasis Treatment.

Journal: Journal of medicinal chemistry

Published: August 16, 2024

Synthesis and biological evaluation of novel isoxazoloquinone derivatives as potent STAT3-targeting antipsoriasis agents.

Synthesis and biological evaluation of novel isoxazoloquinone derivatives as potent STAT3-targeting antipsoriasis agents.

Journal: Bioorganic chemistry

Published: May 08, 2024

Engineering Versatile Bacteria-Derived Outer Membrane Vesicles: An Adaptable Platform for Advancing Cancer Immunotherapy.

Engineering Versatile Bacteria-Derived Outer Membrane Vesicles: An Adaptable Platform for Advancing Cancer Immunotherapy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 02, 2024

Spinosyn A and Its Derivative Inhibit Colorectal Cancer Cell Growth via the EGFR Pathway.

Spinosyn A and Its Derivative Inhibit Colorectal Cancer Cell Growth via the EGFR Pathway.

Journal: Journal of natural products

Published: September 08, 2023

An Isoxazoloquinone Derivative Inhibits Tumor Growth by Targeting STAT3 and Triggering Its Ubiquitin-Dependent Degradation.

An Isoxazoloquinone Derivative Inhibits Tumor Growth by Targeting STAT3 and Triggering Its Ubiquitin-Dependent Degradation.

Journal: Cancers

Published: March 17, 2023

Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor.

Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor.

Journal: Nature communications

Published: February 28, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026